NEO7

Neo7Logix is a precision medicine company specializing in the design and manufacture of personalized peptide-based immunotherapies. Utilizing advanced computational algorithms and molecular modeling, the company identifies patient-specific neoantigens to develop targeted treatments for cancer, neurodegenerative disorders, and infectious diseases. Their platform focuses on the rapid deployment of individualized therapies, aiming to overcome the limitations of "one-size-fits-all" medical approaches. Neo7Logix operates at the intersection of bioinformatics and immunology to provide tailored therapeutic solutions for patients with complex or refractory conditions.